Heights Capital Management’s DNA X SONM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-557
Closed -$811K – 114
2020
Q2
$811K Buy
+557
New +$890K 0.3% 37

Other funds holding SONM

Heights Capital Management's SONM Position: Q3 2020 in Review

Heights Capital Management sold out of DNA X (SONM) in Q3 2020, closing a stake of 557 shares — an estimated $811K sold.

Heights Capital Management first reported a position in SONM in Q2 2020 and held it in 1 quarter. The position peaked at $811K in Q2 2020. 34 funds tracked by Wall St. Rank hold SONM as of Q3 2020.

  • Heights Capital Management reported no remaining DNA X position as of Q3 2020 after selling out during the quarter.
  • Heights Capital Management sold 557 DNA X shares in Q3 2020, an estimated $811K.
  • Heights Capital Management first reported a position in DNA X in Q2 2020 and held it in 1 quarter.
  • Heights Capital Management's DNA X position peaked at $811K in Q2 2020.
  • 34 funds tracked by Wall St. Rank held DNA X as of Q3 2020.

Based on Heights Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.